Clinical Trials in Jiyuan, China
3 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 3
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Kidney Disease, Chronic
Boehringer Ingelheim11,000 enrolled399 locationsNCT06531824
Recruiting
Observation Study on Reducing the Risk of Liver Cancer Associated With Hepatitis B (Zhiyuan) Project.
Chronic Hepatitis B
The First Affiliated Hospital of Zhengzhou University15,000 enrolled162 locationsNCT07169656